What Lenacapavir Means for HIV Prevention in Africa
NAIROBI, February, 2026 –The introduction of long-acting HIV prevention marks a significant step in Africa’s response to the epidemic. With Lenacapavir now available in countries such as Kenya, attention is turning to what it will take to ensure equitable access and sustainable delivery. In this interview, Dr Githinji Gitahi, Group CEO of Amref Health Africa,…